Record Status This is a bibliographic record of a published health technology assessment. No evaluation of the quality of this assessment has been made for the HTA database. Citation Medical Services Advisory Committee. Transurethral injection of botulinum toxin into the ladder wall for urinary incontinence due to neurogenic detrusor overactivity. Canberra: Medical Services Advisory Committee (MSAC). MSAC application 1221. 2012 Authors' conclusions After considering the strength of the available evidence in relation to the safety, clinical effectiveness and cost-effectiveness of the injection of botulinum toxin in the treatment of urinary incontinence related to neurogenic detrusor overactivity, MSAC deferred the application until its responses to PBAC's requests, its other advice, and further information from the applicant, are considered by PBAC. If PBAC refers more matters to MSAC for advice, or the applicant has reason to disagree with the advice given above, MSAC will
support an expedited process for reconsideration. If PBAC subsequently decides to recommend to the Minister that botulinum toxin be listed on the PBS for the treatment of urinary incontinence related to neurogenic detrusor overactivity, MSAC will support an expedited process for reconsideration, to align MSAC support for public funding of the injection of botulinum toxin according to the circumstances recommended by PBAC. The purpose of this reconsideration would be to align the proposed MBS item descriptor with the
proposed PBS restriction; consider the exclusion of other items to be billed to the patient on the same occasion of service; and consider changes in the estimates of costs to the MBS. MSAC also advised the Minister that the current MBS item 36581 should be rewritten to exclude its use for injecting botulinum toxin at a time considered reasonable.
Indexing Status Subject indexing assigned by CRD MeSH Botulinum Toxins, Type As; Neuromuscular Agents; Urinary Bladder, Neurogenic; Urinary Incontinence Language Published English Country of organisation Australia English summary An English language summary is available. Address for correspondence MDP 106, GPO Box 9848, Canberra ACT 2601 AUSTRALIA Email: msac.secretariat@health.gov.au AccessionNumber 32015000418 Date abstract record published 07/04/2015 |